Abstract

THE OBJECTIVEwas to report our experience of endovascular treatment in patients with acute thromboembolic occlusion of the superior mesenteric artery (SMA).METHODS AND MATERIALS. 13 patients with acute thromboembolic occlusion of the SMA underwent endovascular intervention. There were 4 (31 %) men and 9 (69 %) women. The average age was 76±9 years. The time from the beginning of the disorder to intervention and mechanical reperfusion of the SMA ranged from 4 to 65 hours, averaging (22±17) hours. Initial leukocytosis was (16.5±5.8)·10/9 l (from 9.2 to 28.8·10/9 l). Various endovascular manipulations were applied to achieve artery reperfusion: mechanical recanalization, balloon angioplasty, aspiration thrombectomy and stenting.RESULTS. Complete recovery of antegrade blood flow through the SMA and its main branches was achieved at all 13 (100 %) patients. Laparotomy was executed at 4 (31 %) patients, thus the intestinal necrosis after endovascular intervention developed in 3 (23 %) cases. The lethal outcome was 46 %. The main reason for a lethal outcome was reperfusion syndrome (4 patients, 31 %).CONCLUSION. Endovascular methods of treatment of patients with acute thromboembolic occlusion of the SMA can be considered as the first step in medical algorithm. They allow to save intestinal viability in most patients. Reperfusion syndrome was the main reason for a lethal outcome. The development of methods for the prevention and treatment of reperfusion syndrome in acute thromboembolic occlusion of the SMA has to become the basis for successful treatment of these patients.

Highlights

  • Received 15.08.19; accepted 11.12.19 The OBJECTIVE was to report our experience of endovascular treatment in patients with acute thromboembolic occlusion of the superior mesenteric artery (SMA)

  • Endovascular methods of treatment of patients with acute thromboembolic occlusion of the SMA can be considered as the first step in medical algorithm

  • Reperfusion syndrome was the main reason for a lethal outcome

Read more

Summary

ЭНДОВАСКУЛЯРНОЕ ЛЕЧЕНИЕ ПАЦИЕНТОВ С ТРОМБОЭМБОЛИЕЙ ВЕРХНЕЙ БРЫЖЕЕЧНОЙ АРТЕРИИ

Продемонстрировать опыт эндоваскулярного лечения пациентов с тромбоэмболией верхней брыжеечной артерии (ВБА). В клинике эндоваскулярному вмешательству подверглись 13 пациентов с тромбоэмболией ВБА. Эндоваскулярные методы лечения тромбоэмболии ВБА можно рассматривать в качестве первого шага в лечебном алгоритме. Разработка методов профилактики и алгоритма лечения реперфузионного синдрома при острой окклюзии ВБА должна явиться основой успеха в лечении этих пациентов. Ключевые слова: острое нарушение мезентериального кровообращения, эндоваскулярное лечение, тромбо­ эмболия верхней брыжеечной артерии Для цитирования: Хрипун А. А. Эндоваскулярное лечение пациентов с тромбоэмболией верхней брыжеечной артерии. Received 15.08.19; accepted 11.12.19 The OBJECTIVE was to report our experience of endovascular treatment in patients with acute thromboembolic occlusion of the superior mesenteric artery (SMA). 13 patients with acute thromboembolic occlusion of the SMA underwent endovascular intervention. The time from the beginning of the disorder to intervention and mechanical reperfusion of the SMA ranged from 4 to 65 hours, averaging (22±17) hours. Various endovascular manipulations were applied to achieve artery reperfusion: mechanical recanalization, balloon angioplasty, aspiration thrombectomy and stenting

RESULTS
Соответствие нормам этики
Compliance with ethical principles
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.